Biologics

Regenexx Network Using Regenerative Medicine Technologies in Interventional Orthopedics to Treat Pain
Biologics

Regenexx Network Using Regenerative Medicine Technologies in Interventional Orthopedics to Treat Pain

BROOMFIELD, Colo., April 17, 2017 /PRNewswire/ — “Interventional orthopedics in pain medicine practice” was recently published by Elsevier as a chapter in Techniques in Regional Anesthesia and Pain Management. The chapter, authored by Regenexx® founder Christopher J. Centeno, MD examines less invasive ways to treat orthopedic pain and injuries through […]

BONESUPPORT™ appoints Michael Diefenbeck as Chief Medical Officer
Biologics Top Stories

BONESUPPORT™ appoints Michael Diefenbeck as Chief Medical Officer

Lund, Sweden, 11th April, 2017 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids caused by trauma, infection, disease or related surgery, announces the appointment of Michael Diefenbeck MD PhD as Chief Medical Officer. Dr Diefenbeck founded Scientific Consulting in Orthopaedic Surgery in […]

Acelity Names R. Andrew Eckert President and Chief Executive Officer
Biologics Top Stories

Acelity Names R. Andrew Eckert President and Chief Executive Officer

April 05, 2017 SAN ANTONIO–(BUSINESS WIRE)–Acelity L.P. Inc., a leading global advanced wound care company, today announced that it has named R. Andrew Eckert as President and Chief Executive Officer. Eckert succeeds Joseph Woody, who is leaving Acelity following the successful divestiture of the company’s LifeCell division earlier this year. […]

Cesca Therapeutics Announces Senior Management Promotions
Biologics

Cesca Therapeutics Announces Senior Management Promotions

RANCHO CORDOVA, Calif., April 03, 2017 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the following senior management promotions, effective immediately. Ms. Haihong Zhu, who most recently served as Director of Sales, has been promoted to the […]

Osiris Therapeutics Launches Prestige™ Lyotechnology, a Novel Method for Ambient Storage of Living Cells and Tissues
Biologics

Osiris Therapeutics Launches Prestige™ Lyotechnology, a Novel Method for Ambient Storage of Living Cells and Tissues

COLUMBIA, Md., March 30, 2017 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today that it has developed cutting edge technology enabling the preservation of living cells and tissues at ambient […]

CollPlant Provides Commercial and Operational Update
Biologics Sports Medicine

CollPlant Provides Commercial and Operational Update

NESS ZIONA, Israel, March 30, 2017 /PRNewswire CollPlant (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products (recombinant human, “rhCollagen”), today provided a commercial and operational update in its annual reports. Most recently, in November 2016, the Company announced the signing of an […]

Liquidmetal® Passes Implant Study
Biologics

Liquidmetal® Passes Implant Study

March 28, 2017 RANCHO SANTA MARGARITA, Calif.–(BUSINESS WIRE)–Liquidmetal® Technologies, Inc. (OTCQB: LQMT; the “Company”),announced today that it has passed additional pre-screening biocompatibility tests for use in medical implants and is now pursuing collaborations with medical implant companies. In February of 2017, LQMT received long-term implantation results from parts 3, 10, […]

Burst Biologics Initiates Prospective Multicenter Clinical Study in Spinal Fusion
Biologics

Burst Biologics Initiates Prospective Multicenter Clinical Study in Spinal Fusion

March 28, 2017 BOISE, Idaho–(BUSINESS WIRE)–Burst Biologics has received IRB approval to begin a multicenter prospective clinical study in spinal fusion patients. This study will be conducted using BioBurst Fluid, a cellular allograft derived from umbilical cord blood (UCB) which has shown very promising results in spinal fusion procedures. Fifteen […]

Safety and Efficacy of New Class of Orthopedic Implant for Intramedullary Biologic Stabilization of Fractured Long Bones Studied Out to 1 Year
Biologics Extremities

Safety and Efficacy of New Class of Orthopedic Implant for Intramedullary Biologic Stabilization of Fractured Long Bones Studied Out to 1 Year

March 23, 2017 LEXINGTON, Mass.–(BUSINESS WIRE)–CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education, and advancement of medical technologies, announced today it has published safety and efficacy data at one year showing that percutaneous intramedullary fixation can provide for stabilization of bone fractures while avoiding the need for […]